questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of developing new NICE criteria for rare conditions that do not meet the 300 patient threshold for the Highly Specialised Technology appraisal system.
answerText: Decisions on whether medicines should be evaluated through the National Institute for Health and Care Excellence’s (NICE) highly specialised technologies (HST) programme are taken by NICE itself against a set of published criteria that have been developed...
heading: Rare Diseases: Medical Treatments